Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline –– Interim ...

Groundbreaking HIV cure study in South Africa shows the safety and potential efficacy of a novel therapeutic regimen in women ...

TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a clinical study evaluating TMB-365/TMB-380 ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the ...

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

Consider liver biopsy if HBV DNA > 20,000 IU/ml, ALT ≤2 x ULN and age > 40 years or family history of HCC Consider therapy if histologic disease and ALT ≤2 x ULN HBV DNA ≥20,000 IU/ml and ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...